Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Subscribe
Programme
Keywords
Africa
Alcohol
Asia
Basic research
Behavioural addictions
Cannabis
Capacity-building
Civil society
Clinical research/practice
Comorbidity
COVID-19
Criminal justice/prisons
Criminology
Drug user's perspectives
E-health/digitalisation
ECR (Early Career Researchers)
Europe
Gender perspectives
Harm reduction
Health inequalities
Hepatitis
HIV
Infectious diseases
Markets
Mental health and wellbeing
Monitoring and evaluation
Neuroscience
New psychoactive substances
Nicotine/tobacco
North America
Oceania
Opiates
Overdose
Policy
Prescription drugs
Prevention
Psychostimulants
Public health
Qualitative methods
Quantitative methods
Recreational setting
Risky behaviours
South America
Toxicology and forensic analysis
Treatment
Underrepresented groups
Workforce
Youth/children
- Any -
WED
23 OCT
THU
24 OCT
FRI
25 OCT
All
Plenary session
Big debate
Major session
Workshop
Oral presentation session
Short communication session
e-short communication session
e-poster session
Video contest
PDF version
Wed 23 Oct
10:00
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
11:50
Advances in drug treatment
11:50
to
13:20
Auditorium II
Oral presentation session
Advances in drug treatment
11:50
to
13:20
Auditorium II
Oral presentation session
Innovative health approaches
11:50
to
13:20
Auditorium III
Oral presentation session
Innovative health approaches
11:50
to
13:20
Auditorium III
Oral presentation session
Sex, gender and diversity in drugs
11:50
to
13:20
Auditorium IV
Oral presentation session
Advancing addiction research: global perspectives and collaborative initiatives
11:50
to
13:20
Auditorium VI
Oral presentation session
Lives at risk: mental health and substance use
11:50
to
13:20
Auditorium VII
Oral presentation session
Prevalence of opioids and related harms
11:50
to
13:20
Auditorium VIII
Oral presentation session
Mechanisms and outcomes in substance use prevention among youth
11:50
to
13:20
Room 5A
Oral presentation session
Gambling: work-related, financial, and criminological issues
11:50
to
13:20
Room 5B
Oral presentation session
Gambling: work-related, financial, and criminological issues
11:50
to
13:20
Room 5B
Oral presentation session
Support for recovery
11:50
to
13:20
Room 1.07
Short communication session
14:20
Alcohol use in the young
14:20
to
15:50
Auditorium II
Oral presentation session
Neuroscience and cognition
14:20
to
15:50
Auditorium III
Short communication session
Tobacco, mental health and other substance use
14:20
to
15:50
Auditorium VII
Oral presentation session
Gender and substance use
14:20
to
15:50
Auditorium VIII
Oral presentation session
Substance use interventions in youth
14:20
to
15:50
Room 5A
Oral presentation session
Substance use interventions in youth
14:20
to
15:50
Room 5A
Oral presentation session
Neurocognitive processes in behavioural addictions
14:20
to
15:50
Room 5B
Oral presentation session
Challenge of measuring use and impact of cannabinoids
14:20
to
15:50
Room 1.07
Oral presentation session
Methods and measurement
14:20
to
15:50
Room 1.08
Short communication session
Methods and measurement
14:20
to
15:50
Room 1.08
Short communication session
Methods and measurement
14:20
to
15:50
Room 1.08
Short communication session
16:00
Infectious diseases in people who inject drugs
16:00
to
17:30
Auditorium IV
Oral presentation session
Infectious diseases in people who inject drugs
16:00
to
17:30
Auditorium IV
Oral presentation session
Measuring drug market phenomenon
16:00
to
17:30
Auditorium VI
Oral presentation session
Surveillance of drug-related morbidity and mortality
16:00
to
17:30
Room 5A
Oral presentation session
Assessment of behavioural addictions
16:00
to
17:30
Room 5B
Oral presentation session
Responses to behavioural addictions
16:00
to
17:30
Room 1.05
Short communication session
Problematic gambling and gaming
16:00
to
17:30
Room 1.07
Short communication session
Conceptualising health and harms
16:00
to
17:30
Room 1.08
Short communication session
Conceptualising health and harms
16:00
to
17:30
Room 1.08
Short communication session
Conceptualising health and harms
16:00
to
17:30
Room 1.08
Short communication session
17:50
NPS: trends, concerns and response strategies
17:50
to
19:20
Auditorium III
Oral presentation session
NPS: trends, concerns and response strategies
17:50
to
19:20
Auditorium III
Oral presentation session
Drug use trends
17:50
to
19:20
Auditorium IV
Oral presentation session
Understanding interrelationships: mental health and substance use
17:50
to
19:20
Auditorium VII
Oral presentation session
Novel and contextual approaches in prevention
17:50
to
19:20
Room 5A
Oral presentation session
Motivations for use
17:50
to
19:20
Room 5C
Oral presentation session
Hepatitis C, HIV, and other drug related harms
17:50
to
19:20
Room 1.05
Short communication session
Hepatitis C, HIV, and other drug related harms
17:50
to
19:20
Room 1.05
Short communication session
Opioids: trends, use and treatments
17:50
to
19:20
Room 1.06
Short communication session
Opioids: trends, use and treatments
17:50
to
19:20
Room 1.06
Short communication session
Thu 24 Oct
11:50
Opioid treatment 2
11:50
to
13:20
Auditorium III
Oral presentation session
Emerging drug harms, DCRs and other responses
11:50
to
13:20
Auditorium VII
Short communication session
Contemporary issues
11:50
to
13:20
Room 1.08
Oral presentation session
14:20
Novel neurobiology - cannabis, cognition and craving
14:20
to
15:50
Auditorium III
Oral presentation session
Understanding drug-related deaths
14:20
to
15:50
Auditorium IV
Oral presentation session
Young people, mental health and substance use
14:20
to
15:50
Auditorium VII
Oral presentation session
Co-creating robust systems with workers
14:20
to
15:50
Room 5C
Oral presentation session
Understanding harm reduction: economic, social, and health perspectives
14:20
to
15:50
Room 1.05
Short communication session
European prevention curriculum: increasing the use of evidence-based prevention
14:20
to
15:50
Room 1.06
Short communication session
Women's realities of drug use
14:20
to
15:50
Room 1.08
Oral presentation session
16:00
Cannabis legalisation — models and impacts
16:00
to
17:30
Auditorium VI
Oral presentation session
Cannabis legalisation — models and impacts
16:00
to
17:30
Auditorium VI
Oral presentation session
Protective and risk factors in drug prevention
16:00
to
17:30
Room 5A
Oral presentation session
Policy issues in gambling
16:00
to
17:30
Room 5B
Oral presentation session
From genes to brains
16:00
to
17:30
Room 1.06
Short communication session
17:50
Viral hepatitis among people who inject drugs
17:50
to
19:20
Auditorium IV
Oral presentation session
New Research on Alcohol and Tobacco Policy
17:50
to
19:20
Room 5A
Oral presentation session
Hospital-based treatments
17:50
to
19:20
Room 5B
Oral presentation session
From old to new: changes in drug use
17:50
to
19:20
Room 5C
Oral presentation session
From old to new: changes in drug use
17:50
to
19:20
Room 5C
Oral presentation session
Behavioural addictions, prevention and theory
17:50
to
19:20
Room 1.05
Short communication session
Behavioural addictions, prevention and theory
17:50
to
19:20
Room 1.05
Short communication session
Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform
17:50
to
19:20
Room 1.06
Short communication session
Fri 25 Oct
11:50
Gaming and social media use
11:50
to
13:20
Auditorium III
Oral presentation session
Psychedelics 2
11:50
to
13:20
Auditorium VI
Oral presentation session
Trauma and substance use
11:50
to
13:20
Auditorium VII
Oral presentation session
Drugs checking services
11:50
to
13:20
Room 5A
Oral presentation session
Drugs checking services
11:50
to
13:20
Room 5A
Oral presentation session
Substance use and treatment needs across European prisons
11:50
to
13:20
Room 5C
Oral presentation session
Emerging challenges in drug markets: monitoring, measurement & impacts
11:50
to
13:20
Room 1.05
Short communication session
Emerging challenges in drug markets: monitoring, measurement & impacts
11:50
to
13:20
Room 1.05
Short communication session
Gaming and health
11:50
to
13:20
Room 1.06
Short communication session
14:20
Young people and drugs
14:20
to
15:50
Auditorium III
Oral presentation session
Addressing diverse treatment needs
14:20
to
15:50
Auditorium VI
Oral presentation session
Substance use and mental health in prison settings
14:20
to
15:50
Auditorium VII
Oral presentation session
Prevention and addiction in underrepresented groups
14:20
to
15:50
Room 5A
Oral presentation session
16:00
Novel psychoactive substances and latest drug trends in Asia and Pacific countries
16:00
to
17:30
Room 1.05
Oral presentation session
MENU
Back
www.lisbonaddictions.eu
My profile
Notifications
My favourites
Scan contacts
My contacts
Settings